Department of Radiotherapy, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Department of Radiotherapy, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
J Med Imaging Radiat Sci. 2021 Mar;52(1):57-67. doi: 10.1016/j.jmir.2020.12.004. Epub 2021 Jan 26.
Deep inspiration breath hold (DIBH) reduces heart and pulmonary doses during left-sided breast radiation therapy (RT); however, there is limited information whether the reduction in doses is similar in patients with modified radical MRM (MRM) and breast conservation surgery (BCS). The primary objective was to determine whether DIBH offers greater dosimetric reduction in cardiac doses in patients with MRM as compared to BCS with secondary objectives of documenting time consumed in counseling, simulation and planning such techniques.
Thirty patients with diagnosis of left sided breast cancer underwent CT simulation both free breathing (FB) and DIBH. Patients were grouped into two cohorts: MRM (n = 20) and BCS (n = 10). 3D-conformal plans were developed and FB was compared to DIBH for entire group (n = 30) and each cohort using Wilcoxon signed-rank tests for continuous variables and McNemar's test for discrete variables. The percent relative reduction conferred by DIBH in mean heart (D heart) and left anterior descending artery dose (LAD and LAD), heart V25,V10, V2 and ipsilateral DLung,V20, V12 were compared between the two cohorts using Wilcox rank-sum testing. A two-tailed p-value ≤ 0.05 was considered statistically significant. Time consumed during FB and DIBH from patient counseling to planning was documented.
Patients undergoing BCS had comparable boost target coverage on DIBH and FB. For the overall group (n = 30), DIBH reduced D heart and LAD dose, V25, V10 and V2 doses for the heart and Ipsilateral DLung, V20, V12 which was statistically significant. For individual cohorts DIBH did not significantly reduce the lung (Ipsilateral DLung, V20, V12) and LAD (LAD and LAD) doses for BCS while significant reduction in all cardiopulmonary doses was seen in MRM cohort. Despite significant reductions with DIBH in MRM, ipsilateral lung constraint of V12 < 15% was less commonly achieved in MRM (n = 11, 55%) requiring nodal radiation as compared to BCS (n = 3, 30%). Percent reduction in all cardiac and pulmonary dosimetric parameters with DIBH was similar in the MRM cohort as compared to BCS cohort. In total 73.1 ± 2.6 min was required for FB as compared to 108.1 ± 4.1 min in DIBH.
DIBH led to significant reduction of cardiac doses in both MRM and BCS. Reduction of lung and LAD doses were significant in MRM cohort. All cardiac constraints were met with DIBH in both cohorts, lung constraints were less frequently met in MRM cohort requiring nodal radiation.
深吸气屏气(DIBH)可降低左侧乳腺癌放疗期间的心脏和肺剂量;然而,关于改良根治性乳房切除术(MRM)和保乳手术(BCS)患者剂量降低是否相似的信息有限。主要目的是确定 DIBH 是否能为 MRM 患者提供比 BCS 患者更大的心脏剂量的剂量学降低,次要目的是记录咨询、模拟和计划这些技术所消耗的时间。
30 例左侧乳腺癌患者在自由呼吸(FB)和 DIBH 下进行 CT 模拟。患者分为两组:MRM(n=20)和 BCS(n=10)。为整个组(n=30)和每个队列开发了 3D 适形计划,并使用 Wilcoxon 符号秩检验比较 FB 和 DIBH 之间的连续变量,使用 McNemar 检验比较离散变量。使用 Wilcox 秩和检验比较两组之间 DIBH 对平均心脏(D 心)和左前降支剂量(LAD 和 LAD)、心脏 V25、V10、V2 和同侧 DLung、V20、V12 的相对减少百分比。双侧 p 值≤0.05 被认为具有统计学意义。记录从患者咨询到计划的 FB 和 DIBH 期间所消耗的时间。
接受 BCS 的患者在 DIBH 和 FB 上的靶区覆盖有可比性。对于整个组(n=30),DIBH 降低了 D 心和 LAD 剂量、心脏 V25、V10 和 V2 剂量以及同侧 DLung、V20、V12,这具有统计学意义。对于各个队列,DIBH 并没有显著降低 BCS 患者的肺(同侧 DLung、V20、V12)和 LAD(LAD 和 LAD)剂量,而 MRM 队列中所有心肺剂量均显著降低。尽管 DIBH 在 MRM 中显著降低,但在 MRM 中同侧肺 V12 < 15%的限制(n=11,55%)比 BCS 中(n=3,30%)更常见,需要进行淋巴结放疗。与 BCS 队列相比,DIBH 对所有心脏和肺剂量学参数的降低百分比在 MRM 队列中相似。FB 总共需要 73.1±2.6 分钟,而 DIBH 需要 108.1±4.1 分钟。
DIBH 可显著降低 MRM 和 BCS 患者的心脏剂量。MRM 队列中肺和 LAD 剂量的降低具有显著意义。两个队列均满足所有心脏限制,MRM 队列中肺限制不太常见,需要进行淋巴结放疗。